New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the October 2015 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the October issue!
PharmSource Lead Sheet Global Activity Report:
|Lead Type||September 2015||2015 YTD|
|Total Drug Leads||361||3489|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Follow the Money: Trevena, Inc.
Trevena, Inc. is a U.S. public pharmaceutical company that discovers and develops pharmaceutical products targeting G protein-coupled receptors. Trevena expects to raise $63.4 million in the completion of a secondary public offering.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds for working capital and general purposes, as well as for product development, including… read on
MediciNova plans to initiate a Phase II clinical trial with MN-001 for the treatment of idiopathic pulmonary fibrosis:
- Therapeutic Area: Anti-inflammatory
- Dosage Form: Tablet
- API: Chemical – Normal potency
- Benchmark your performance against other CMOs in the industry
- Understand what strategies CMOs are pursuing for profitable growth
- Grasp CMO business challenges affecting bio/pharmaceutical negotiations
New Report Available: PharmSource CMO Industry Analysis
Our just-released 2015 Contract Dose Manufacturing Industry by the Numbers report is an indispensable resource for understanding the competitive environment faced by dose manufacturers, and provides critical insights for your strategic planning efforts. The report will enable you to:
Thanks to our deep expertise and ongoing research, Contract Dose Manufacturing Industry by the Numbers is the most authoritative and reliable portrait of the CMO industry available to the bio/pharmaceutical industry today.
Our proprietary model and assumptions are fully explained so you can understand how we arrived at our analysis and conclusions.
You won’t find this mission-critical information in any other source. Click here for more information or to order this report today.
Identifying Atypical Opportunities using PharmSource Lead Sheet
by Saul Richmond, Director, Market Intelligence
Contract service providers that specialize in “non-standard” dose forms can use the PharmSource Lead Sheet’s detailed dosage form options to zero-in on opportunities appropriate to their capabilities. The system offers over 30 different dosage form categories, enabling you to shine the spotlight exactly where it suits your needs.
Here’s an example of just four of the 30+ dosage form categories. In the combined months of June and July 2015, the PharmSource Lead Sheet reported a total of 150 leads for… read on
True or False: Annual reviews improve employee sales performance
According to a study done by SHRM, 97% of its member organizations conduct regular performance reviews, yet just 2% received a grade of “A” for effectively managing performance reviews. Done right, annual performance evaluations require a significant time commitment from sales managers, and this time suck grows exponentially based on the size of the sales team. There may be a less cumbersome way to both assess and improve sales performance… read on
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / 1-703-383-4903, ext. 112 (ET USA).